Published in Arch Med Sci on December 19, 2012
The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Physiol Rev (2015) 0.97
Arg389Gly β1-adrenergic receptor polymorphism and susceptibility to syncope during tilt test. Arch Med Sci (2014) 0.82
Tangent function transformation of the Abbreviated Injury Scale improves accuracy and simplifies scoring. Arch Med Sci (2015) 0.80
Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3. BMC Bioinformatics (2016) 0.75
In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope. Front Neurosci (2016) 0.75
Bacillus bombysepticus α-Toxin Binding to G Protein-Coupled Receptor Kinase 2 Regulates cAMP/PKA Signaling Pathway to Induce Host Death. PLoS Pathog (2016) 0.75
Alteration of gene expression profiling including GPR174 and GNG2 is associated with vasovagal syncope. Pediatr Cardiol (2014) 0.75
Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev (2001) 6.50
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation (2002) 3.22
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A (1998) 2.76
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med (2007) 2.48
beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci U S A (2003) 2.43
The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem (1993) 2.33
G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res (2008) 2.22
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A (1996) 2.06
Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A (2001) 1.97
Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol (2008) 1.81
Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal (2003) 1.71
Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem (1997) 1.71
Muscarinic receptors in the mammalian heart. Pharmacol Res (2001) 1.64
G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension (2009) 1.62
Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem (2001) 1.55
Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal (2005) 1.55
The beta-adrenergic receptors. Herz (2002) 1.48
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells. J Hum Hypertens (2010) 1.42
Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity. Hypertension (2000) 1.38
Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol (2002) 1.38
Lipids, blood pressure, kidney - what was new in 2011? Arch Med Sci (2011) 1.37
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur Heart J (2012) 1.35
Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol (2009) 1.34
GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol (2010) 1.31
Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension (2012) 1.29
Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension (2002) 1.22
G-Protein-coupled receptor kinase activity in hypertension : increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension (2000) 1.22
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol (2011) 1.19
Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology. Circ Res (2011) 1.19
Activation by G protein beta gamma subunits of agonist- or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J Biol Chem (1992) 1.18
Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. Circulation (2004) 1.17
Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization. J Mol Cell Cardiol (2004) 1.15
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients. Pharmacogenet Genomics (2011) 1.12
Heart disease in diabetic patients. Curr Diab Rep (2003) 1.09
The beta-adrenergic receptor kinase in heart failure. J Mol Cell Cardiol (2003) 1.06
Regulation of GPCR signaling in hypertension. Biochim Biophys Acta (2010) 1.02
β₂ AR agonists in treatment of chronic heart failure: long path to translation. J Mol Cell Cardiol (2010) 1.00
Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res (2010) 1.00
Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure. Mol Pharmacol (2009) 1.00
Takotsubo cardiomyopathy or broken heart syndrome: A review article. J Res Med Sci (2011) 1.00
G-protein-coupled receptor kinase activity in human heart failure: effects of beta-adrenoceptor blockade. Cardiovasc Res (2005) 0.99
Familial vasovagal syncope. Europace (2005) 0.99
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin Transl Sci (2008) 0.96
Central and baroreflex control of heart rate during the wake-sleep cycle in rat. Sleep (2001) 0.94
Is vasovagal syncope a disease? Europace (2007) 0.92
Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens (2011) 0.89
Central actions of the chemokine stromal cell-derived factor 1 contribute to neurohumoral excitation in heart failure rats. Hypertension (2012) 0.89
Two kinases mediate agonist-dependent phosphorylation and desensitization of the beta 2-adrenergic receptor. Symp Soc Exp Biol (1990) 0.89
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol (1998) 0.87
The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension. J Pharmacol Exp Ther (2008) 0.87
Temporal analysis of the spontaneous baroreceptor reflex during mild emotional stress in the rat. Stress (2010) 0.86
Sleep-dependent changes in the coupling between heart period and arterial pressure in newborn lambs. Pediatr Res (2004) 0.85
Abnormalities of autonomic nervous control in human hypertension. Cardiovasc Drugs Ther (1994) 0.85
Signal transduction in myocardial ischaemia. Eur Heart J (1994) 0.85
Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors. Life Sci (1995) 0.84
Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am Heart J (1990) 0.84
Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation. Angiology (2010) 0.83
Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction. Pflugers Arch (2011) 0.81
Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem Biophys Res Commun (2001) 0.81
Effects of acoustic stimulation on cardiovascular regulation during sleep. Sleep (2003) 0.81
Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog. Am J Cardiol (1974) 0.81
GRK2 and β-arrestins in cardiovascular disease: Something old, something new. Am J Cardiovasc Dis (2011) 0.81
Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferation. Curr Pharm Des (2010) 0.80
Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac beta-adrenergic receptors. Circulation (2000) 0.80
Methodology of monitoring cardiovascular regulation. Vojnosanit Pregl (2012) 0.80
Heart rate variability in children with exercise-induced idiopathic ventricular arrhythmias. Pediatr Cardiol (2010) 0.80
[Atrial fibrillation and the autonomic nervous system]. Z Kardiol (1994) 0.79
A novel approach to syncopal patients: association analysis of polymorphisms in G-protein genes and tilt outcome. Europace (2009) 0.78
Sleep-related changes in the regulation of cerebral blood flow in newborn lambs. Sleep (2004) 0.78
[Cardiovascular regulation as a function of age. Determinants of antihypertensive treatment based on beta-blockers and calcium inhibitors]. Arch Mal Coeur Vaiss (1985) 0.77
Catechol-O-methyltransferase: potential relationship to idiopathic hypertension. Arch Med Sci (2010) 0.77
Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Blood Press Suppl (1995) 0.77
G protein-coupled receptor kinase: phosphorylation of muscarinic receptors and facilitation of receptor sequestration. Adv Pharmacol (1996) 0.76
Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy. Clin Physiol Funct Imaging (2009) 0.76
[The electrocardiology of atrial fibrillation]. Ital Heart J Suppl (2000) 0.76
Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy (2011) 1.22
AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. Biochem Pharmacol (2009) 1.02
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease. Proteins (2008) 0.90
Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo. BJU Int (2008) 0.88
Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis. Atherosclerosis (2010) 0.86
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int (2007) 0.85
Immunomodulatory actions of central ghrelin in diet-induced energy imbalance. Brain Behav Immun (2011) 0.84
Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA. Br J Pharmacol (2010) 0.83
A review of the cardiovascular and anti-atherogenic effects of ghrelin. Curr Pharm Des (2013) 0.83
Pharmacogenetic study of cholesteryl ester transfer protein gene and simvastatin treatment in hypercholesterolaemic subjects. Expert Opin Pharmacother (2007) 0.80
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int (2004) 0.80
Efficacy of remote ischaemic preconditioning for spinal cord protection against ischaemic injury: association with heat shock protein expression. Folia Neuropathol (2008) 0.79
Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int (2007) 0.79
Rapid detection of the hypertension-associated A1166C polymorphism of the angiotensin II type 1 receptor (AGTR1). Genet Test (2002) 0.78
Longitudinal effects of fenfluramine-phentermine use. Angiology (2008) 0.75
A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin-stimulated proliferation of vascular smooth muscle cells. Cell Biol Int (2009) 0.75